Wang Chao, Ciren Pingcuo, Danzeng Awang, Li Yong, Zeng Cheng-Long, Zhang Zhi-Wei, Huang Zhi-Yong, Chen Yi-Fa, Zhang Wan-Guang, Zhang Bi-Xiang, Zhang Bin-Hao, Chen Xiao-Ping
Hepatic Surgery Center, Institute of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
J Oncol. 2022 Oct 25;2022:4446243. doi: 10.1155/2022/4446243. eCollection 2022.
Intrahepatic cholangiocarcinoma (ICC) is the second most common liver malignancy after hepatocellular carcinoma (HCC), with a dismal prognosis and high heterogeneity. The oncological advantages of anatomical resection (AR) and nonanatomical resection (NAR) in HCC have been studied, but surgical strategies for ICC remain controversial with insufficient investigations.
From Jan 2013 to Dec 2016, 3880 consecutive patients were retrospectively reviewed from a single center. Patients with ICC undergoing AR or NAR have been enrolled according to inclusion and exclusion criteria. Propensity score matching (PSM) analysis was performed between two groups with a 1 : 1 ratio. The primary endpoint was overall survival (OS), and the secondary endpoints included disease-free survival (DFS), intraoperative patterns, postoperative morbidity, mortality, complications and recurrence. A prognostic nomogram was developed by a multivariate Cox proportion hazard model.
After PSM, 99 paired cases were selected from 276 patients enrolled in this study. Patients in the AR group achieved better 1-, 3-, and 5-year OS (70%, 46%, and 34%, respectively) and DFS (61%, 21%, and 10%, respectively) than patients in the NAR group with statistical significance after PSM analysis. The postoperative complications and recurrence patterns were comparable between the two groups. Multivariate analysis identified NAR, tumor size >5 cm, multiple tumors, and poor differentiation as independent risk factors for OS ( < 0.05). Selected patients can benefit most from AR, according to subgroup analysis. A prognostic nomogram based on six independent risk factors for OS and factors with clinical significance was constructed to predict OS in ICC patients.
AR improved the long-term survival of ICC with comparable postoperative complications and similar recurrence patterns. AR is suggested in ICC patients with sufficient remnant liver volume. In addition to surgery strategy, malignant characteristics of tumors are risk factors for ICC prognosis.
肝内胆管癌(ICC)是仅次于肝细胞癌(HCC)的第二常见肝脏恶性肿瘤,预后不佳且异质性高。HCC中解剖性切除(AR)和非解剖性切除(NAR)的肿瘤学优势已得到研究,但ICC的手术策略仍存在争议,相关研究不足。
回顾性分析2013年1月至2016年12月来自单一中心的3880例连续患者。根据纳入和排除标准,纳入接受AR或NAR的ICC患者。两组进行1∶1比例的倾向评分匹配(PSM)分析。主要终点为总生存期(OS),次要终点包括无病生存期(DFS)、术中情况、术后发病率、死亡率、并发症及复发情况。通过多变量Cox比例风险模型建立预后列线图。
PSM后,从本研究纳入的276例患者中选取99对病例。PSM分析后,AR组患者的1年、3年和5年OS(分别为70%、46%和34%)及DFS(分别为61%、21%和10%)均优于NAR组患者,差异有统计学意义。两组术后并发症及复发情况相当。多变量分析确定NAR、肿瘤大小>5 cm、多发肿瘤及低分化是OS的独立危险因素(P<0.05)。亚组分析显示,特定患者从AR中获益最大。构建了基于OS的六个独立危险因素及具有临床意义的因素的预后列线图,以预测ICC患者的OS。
AR改善了ICC患者的长期生存,术后并发症相当,复发情况相似。对于残余肝体积充足的ICC患者,建议行AR。除手术策略外,肿瘤的恶性特征也是ICC预后的危险因素。